UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 6,640 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 225,618 shares of the electronics maker's stock after buying an additional 6,640 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.24% of Dolby Laboratories worth $17,621,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DLB. Savant Capital LLC boosted its position in Dolby Laboratories by 2.0% during the fourth quarter. Savant Capital LLC now owns 6,274 shares of the electronics maker's stock valued at $490,000 after purchasing an additional 125 shares during the last quarter. Orion Portfolio Solutions LLC lifted its holdings in shares of Dolby Laboratories by 0.7% during the fourth quarter. Orion Portfolio Solutions LLC now owns 19,522 shares of the electronics maker's stock worth $1,525,000 after buying an additional 132 shares in the last quarter. Mather Group LLC. boosted its position in shares of Dolby Laboratories by 36.8% in the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after acquiring an additional 142 shares during the period. Naples Global Advisors LLC grew its stake in shares of Dolby Laboratories by 0.4% in the fourth quarter. Naples Global Advisors LLC now owns 35,730 shares of the electronics maker's stock valued at $2,791,000 after acquiring an additional 160 shares in the last quarter. Finally, Fifth Third Bancorp grew its stake in shares of Dolby Laboratories by 82.7% in the fourth quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after acquiring an additional 163 shares in the last quarter. 58.56% of the stock is owned by institutional investors.

Dolby Laboratories Trading Down 0.5%

Dolby Laboratories stock traded down $0.35 during trading hours on Monday, reaching $73.91. 295,690 shares of the stock were exchanged, compared to its average volume of 452,646. Dolby Laboratories, Inc. has a twelve month low of $66.35 and a twelve month high of $89.66. The company has a market cap of $7.10 billion, a P/E ratio of 27.17 and a beta of 0.95. The stock has a 50 day moving average of $75.17 and a two-hundred day moving average of $78.64.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.29 by $0.05. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The business had revenue of $369.56 million for the quarter, compared to analyst estimates of $375.44 million. During the same quarter last year, the business posted $1.27 EPS. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. On average, analysts expect that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 21st. Stockholders of record on Tuesday, May 13th were paid a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $1.32 annualized dividend and a dividend yield of 1.79%. Dolby Laboratories's payout ratio is 49.81%.

Wall Street Analyst Weigh In

Several analysts have weighed in on DLB shares. Barrington Research reiterated an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, May 2nd. Rosenblatt Securities cut their price target on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Tigress Financial began coverage on Dolby Laboratories in a research report on Thursday, May 15th. They set a "buy" rating and a $112.00 price target on the stock. Finally, Wall Street Zen upgraded Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Friday.

Insider Transactions at Dolby Laboratories

In related news, SVP John D. Couling sold 675 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $75.04, for a total value of $50,652.00. Following the sale, the senior vice president now directly owns 121,151 shares of the company's stock, valued at $9,091,171.04. This trade represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 38.39% of the stock is owned by insiders.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.